Selank is a synthetic peptide studied mainly in a limited set of Russian clinical studies of anxiety disorders. Some participants may describe feeling calmer or less tense, but studies cannot predict an individual response, timeline, or safety profile. The supplied studies do not establish Selank as a U.S. FDA-approved treatment. It is not a substitute for evaluation of anxiety, mood changes, or severe symptoms by a licensed clinician. 1 2 3
Wondering if peptide therapy is right for you? Take the 3-min clinical quiz.
See if you qualify →What might Selank feel like?
The most careful answer is that Selank may feel calming to some people, but there is no dependable “Selank feeling.” The anxiety-focused clinical papers report anxiolytic effects in their studied groups, which may be experienced as less tension or worry. They do not establish that everyone will feel calmer, more focused, sleepy, or noticeably different. 1 2 3
Why “feeling calmer” is the main reported effect in clinical studies
The available human literature centers on anxiety disorders. A 2008 randomized controlled trial examined Selank in generalized anxiety disorder and neurasthenia, while later clinical publications examined Selank in anxiety-disorder treatment and compared anxiolytic effect and tolerability with phenazepam. That focus is why “calmer” or “less anxious” is more grounded than claims about energy, memory, sleep, or longevity. 1 2 3
Why one person’s experience cannot predict another person’s response
The limited published Selank literature does not provide enough information to forecast an individual person’s response or to turn study findings into a personal treatment plan. 1 2 3
What does human research say about Selank and anxiety?
Human research is limited to a small clinical literature, largely involving anxiety-related diagnoses. These publications support saying Selank has been investigated for anxiolytic effects; they do not establish it as a proven option for every form of anxiety or for self-directed use. 1 2 3
What the available randomized and clinical trials studied
| Publication | Population or question | What it can support |
|---|---|---|
| Zozulia and colleagues, 2008 3 | Generalized anxiety disorder and neurasthenia | Selank was investigated as a peptide anxiolytic in these clinical settings. |
| Medvedev and colleagues, 2014 2 | Anxiety disorders; comparison with phenazepam | A comparison of anxiolytic effect and tolerability was reported, but the title alone does not establish that the treatments are interchangeable. |
| Medvedev and colleagues, 2015 1 | Treatment of anxiety disorders | Selank was studied in an anxiety-treatment context. |
What those studies can and cannot establish
The papers support a narrow conclusion: Selank has human clinical research in anxiety-related populations. They do not establish reliable benefits for nootropic use, depression, sleep, cognitive performance, longevity, or general wellbeing. They also cannot tell a reader whether a personal response will be helpful, neutral, unpleasant, or absent. 1 2 3
For a broader evidence review, see our guides to what Selank is and Selank’s anxiety and nootropic claims.
Can Selank cause side effects or unwanted feelings?
Tolerability was examined in a 2014 clinical comparison, but that does not make Selank risk-free or predict a person’s side effects. The supplied publications are too limited to establish a complete side-effect profile, identify every interaction, or define long-term safety. 2 1 3
What tolerability findings in the available clinical literature mean
“Tolerability” means researchers assessed how participants handled a treatment in a particular study. It is not the same as proof of safety across different doses, routes, health conditions, medicines, or long periods of use. The 2014 paper’s title indicates a tolerability comparison with phenazepam, but readers should not treat that as proof that the two substances have the same risks or effects. 2
When anxiety, agitation, mood changes, or other symptoms need medical attention
If you have symptoms that you believe may be urgent—including worsening anxiety, marked agitation, new mood changes, confusion, chest pain, trouble breathing, or thoughts of self-harm—seek prompt medical help. In the United States, call or text 988 for the Suicide & Crisis Lifeline if you are in emotional distress or worried about self-harm.
Does Selank work quickly, and how long might effects last?
There is no reliable personal timeline for how quickly Selank might be felt or how long any effect may last. The supplied clinical publications establish that Selank was studied in anxiety contexts, but they do not provide enough evidence to promise a specific onset or duration for an individual. 1 2 3
Be cautious with online accounts that describe a precise timeline, a guaranteed calm feeling, or a dependable cognitive effect. Personal reports can be useful for understanding what people say online, but they cannot establish safety or predict your response; our review of Selank discussions on Reddit explains that difference.
Is Selank an approved treatment for anxiety?
The supplied publications describe investigational anxiety research, not a U.S. FDA approval decision. A research paper is not an FDA label, and it should not be used to imply that Selank is an FDA-approved U.S. treatment for anxiety or another condition. 1 2 3
Chia’s current catalog does not list Selank. We do not imply that we prescribe, compound, sell, or ship it. For a deeper overview of evidence, safety, and access questions, read our Selank guide.
How does Selank compare with established anxiety care?
Selank is not interchangeable with established anxiety care based on the limited studies available here. The 2014 article compared Selank and phenazepam in anxiety disorders, but a comparison study does not establish equivalence, superiority, or a safe substitution for a clinician-selected treatment. 2
A licensed clinician can help sort out whether symptoms fit an anxiety disorder, another mental-health concern, a medical condition, medication effects, or a stressful life event. That assessment matters because treatment choices should account for symptom severity, other medicines, substance use, pregnancy status, sleep, and safety concerns.
What are safer next steps if you are considering Selank?
The safer next step is a clinician-led conversation before self-treatment. Bring a clear description of your symptoms, when they started, what makes them worse or better, current medicines and supplements, and any past reactions to mental-health treatments.
- Seek urgent help rather than experimenting with a peptide if you have thoughts of self-harm, severe panic, confusion, chest pain, trouble breathing, or rapidly worsening symptoms.
- Avoid treating limited anxiety-study findings as evidence for sleep, cognitive, mood-enhancing, or longevity effects. 1 2 3
- Avoid relying on product claims from no-prescription research-chemical sellers; the limited Selank clinical literature does not establish the quality or appropriateness of products sold outside licensed medical care. 1 2 3
- If you want to discuss anxiety, sleep, or wellbeing goals, talk with a licensed clinician who can evaluate the full picture rather than relying on online anecdotes.
At Chia, our current catalog does not include Selank. We can still be a place to start a clinician-guided conversation about your broader health goals, but a prescription always requires an individual medical evaluation and is never guaranteed.
The supplied clinical studies focus on anxiety-related conditions and do not establish that Selank reliably makes people sleepy. A person’s response cannot be predicted from the limited literature.
A 2014 clinical publication compared Selank with phenazepam, but that comparison does not establish that they feel the same, work the same way, or can be substituted for one another. 2
The available literature is too limited to predict an individual response or fully define adverse effects. New or worsening anxiety, agitation, or mood changes should be discussed promptly with a licensed clinician.
The supplied studies do not provide a reliable personal onset timeline. Online reports of a precise timeline should not be treated as a medical prediction.
The supplied clinical papers are not FDA approval documents and should not be used to present Selank as an FDA-approved U.S. treatment. Check current official FDA information for regulatory questions.
There is limited human clinical literature in anxiety-related populations, but it cannot predict individual benefit, risks, timing, or long-term safety. A clinician can help you discuss evidence-based options for your symptoms.
References
- 1.Medvedev VE, Tereshchenko ON, Kost NV, et al. Optimization of the treatment of anxiety disorders with Selank. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 2015.
- 2.Medvedev VE, Tereshchenko ON, Israelian AIu, et al. A comparison of the anxiolytic effect and tolerability of Selank and phenazepam in the treatment of anxiety disorders. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 2014.
- 3.Zozulia AA, Neznamov GG, Siuniakov TS, et al. Efficacy and possible mechanisms of action of a new peptide anxiolytic Selank in the therapy of generalized anxiety disorders and neurasthenia. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 2008.
- 4.Medvedev VE, Tereshchenko ON, Kost NV, et al. PubMed record for Optimization of the treatment of anxiety disorders with Selank. 2015.
- 5.Medvedev VE, Tereshchenko ON, Israelian AIu, et al. PubMed record for A comparison of the anxiolytic effect and tolerability of Selank and phenazepam in the treatment of anxiety disorders. 2014.
- 6.Zozulia AA, Neznamov GG, Siuniakov TS, et al. PubMed record for Efficacy and possible mechanisms of action of a new peptide anxiolytic Selank in generalized anxiety disorders and neurasthenia. 2008.
- 7.Medvedev VE, Tereshchenko ON, Kost NV, et al. Selank in the treatment of anxiety disorders: indexed clinical publication. 2015.
- 8.Zozulia AA, Neznamov GG, Siuniakov TS, et al. Selank in generalized anxiety disorder and neurasthenia: indexed randomized clinical publication. 2008.
About this article
Chia Health Editorial Team — Evidence-reviewed health education
This article is for educational purposes only and is not a substitute for individualized medical advice. Talk to a licensed clinician before starting, stopping, or changing any prescription.
AI tools may assist with research and drafting. Chia's editorial team reviews source use, clarity, treatment information, and safety framing before publication. A clinician is named only after explicit sign-off. Read our editorial standards.
Get a personalized plan
See if peptide therapy is right for your body.
Our 3-minute clinical quiz is reviewed by a US-licensed clinician. Treatment delivered to your door.



